MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with D

Dapsone

Dapsone 50mg tablets

Use with caution

Stability notes for Dapsone 50mg tablets

Light sensitive medicine. Store in light resistance container.
May discolour when exposed to light. Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the products dapsone 50mg tablets (Accord-UK Ltd) and dapsone 50mg (Aurobindo Pharma - Milpharm Ltd).

Suppliers (9) of Dapsone 50mg tablets
Dapsone 50mg tablets (A A H Pharmaceuticals Ltd)
Dapsone 50mg tablets (Accord-UK Ltd)
Dapsone 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Dapsone 50mg tablets (Almus Pharmaceuticals Ltd)
Dapsone 50mg tablets (Medihealth (Northern) Ltd)
Dapsone 50mg tablets (Milpharm Ltd)
Dapsone 50mg tablets (Rivopharm (UK) Ltd)
Dapsone 50mg tablets (Sigma Pharmaceuticals Plc)
Dapsone 50mg tablets (Tillomed Laboratories Ltd)

Dapsone 100mg tablets

Use with caution

Stability notes for Dapsone 100mg tablets

Light sensitive medicine. Store in light resistance container.
May discolour when exposed to light. Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the products dapsone 100mg tablets (Accord-UK Ltd) and dapsone 100mg (Aurobindo Pharma - Milpharm Ltd).

Suppliers (10) of Dapsone 100mg tablets
Dapsone 100mg tablets (A A H Pharmaceuticals Ltd)
Dapsone 100mg tablets (Accord-UK Ltd)
Dapsone 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Dapsone 100mg tablets (Almus Pharmaceuticals Ltd)
Dapsone 100mg tablets (Medihealth (Northern) Ltd)
Dapsone 100mg tablets (Milpharm Ltd)
Dapsone 100mg tablets (Morningside Healthcare Ltd)
Dapsone 100mg tablets (Rivopharm (UK) Ltd)
Dapsone 100mg tablets (Sigma Pharmaceuticals Plc)
Dapsone 100mg tablets (Tillomed Laboratories Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.